| 21-202 |
Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V., et al. |
Federal Circuit |
2021-08-12 |
Denied |
Amici (3)Relisted (2) |
35-usc-314 35-usc-315 administrative-law appellate-jurisdiction inter-partes-review judicial-review nhk-fintiv-rule patent-trial-and-appeal-board patent-trial-and-appeals-board statutory-interpretation |
Does 35 U.S.C. § 314(d) categorically preclude appeal of all decisions not to institute inter partes review? |
| 20-135 |
Customedia Technologies, LLC v. Dish Network Corporation, et al. |
Federal Circuit |
2020-08-07 |
Denied |
Response Waived |
35-USC-101 Administrative-Procedure-Act Appointments-Clause Due-Process Leahy-Smith-America-Invents-Act patent-eligibility Patent-Eligible-Subject-Matter patent-trial-and-appeals-board ultra-vires |
Whether a court of appeals can invoke forfeiture to refuse to address an Appointments-Clause-violation |
| 18-1144 |
Natural Alternatives International, Inc. v. Andrei Iancu, Director, United States Patent and Trademark Office |
Federal Circuit |
2019-03-05 |
Denied |
Response Waived |
administrative-law agency-deference agency-guidance federal-circuit intellectual-property judicial-review patent-law patent-trial-and-appeal-board patent-trial-and-appeals-board priority property-law property-rights trips |
Did the Court of Appeals for the Federal Circuit err in analyzing rulings by the Patent Trial and Appeals Board |